Article
Directed evolution of a soluble human IL-17A receptor for the inhibition of psoriasis plaque formation in a mouse model.
Chemistry & biology - 21 Feb 2013
Zaretsky Marianna, Etzyoni Revital, Kaye Joel, Sklair-Tavron Liora, Aharoni Amir
Abstract excerpt
Interleukin-17 (IL-17) is a T-cell-derived cytokine that promotes inflammatory pathology in autoimmune diseases. Blocking IL-17A interactions with its endogenous IL-17 receptor (IL-17RA) can constitute an important target for therapeutic intervention. Here, we utilized a directed evolution approach to generate soluble IL-17RA mutants that exhibit increased IL-17A binding affinity and thermostability, relative to...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
